The Centers for Medicare & Medicaid Services … [Read more...]
CMS Proposes Medicare, Medicaid Coverage for Anti-Obesity Drugs
VieMed Q3 Earnings Call: Sleep, Ventilator Business Units Drive Strong Growth
The company also voiced support for reconsideration of the national coverage determination for noninvasive ventilation.
VieMed Healthcare emphasized the importance of … [Read more...]
‘There’s A Lot of Activity’: Why 2025 Is Shaping Up to Be a Big Year for HME
M&A activity is expected to pick up in numerous product segments, including sleep, respiratory, and Complex Rehab Technology.
There’s a good chance of 2025 being a big year for … [Read more...]
Viemed Banking on Emerging Hospital JV Strategy, Recovering from Change Healthcare Disruptions
In an earnings call, Viemed indicated it is hitting its key goals.
In terms of achieving further growth and hitting … [Read more...]
Viemed Healthcare Acquires Majority Interest in East Alabama Health’s HomeMed Business, Assumes Managerial Responsibilities
The acquisition, Viemed CEO Casey Hoyt said, is “a blueprint that can be replicated nationwide.”
Viemed Healthcare Inc. (Nasdaq: VMD) has finalized … [Read more...]
6 Key Quotes from HME Executives That Capture Market Trends
Executives shared their comments during recent earnings calls and industry meetings.
The home medical equipment (HME) market is … [Read more...]
HME Companies Unfazed by GLP-1s – For Now
More earnings calls are including discussions of the impact of these diabetes drugs on HME sales.
GLP-1s agonists – the class of medications that … [Read more...]
‘We Continue to Be Actively Engaged in Multiple Processes’: Viemed Positioned to Ramp Up M&A
Viemed CEO Casey Hoyt discussed emerging opportunities during the company’s Q4/year-end earnings call.
Home-based respiratory care company Viemed … [Read more...]